GC WellBeing affiliate Inibio receives Chinese approval for botulinum toxin 'Inybo'
Predicted impact: Low
Chinese approval for affiliate's botulinum toxin; small relative to parent company's size.
234690 · KOSDAQ · ₩234690 · 녹십자웰빙
Predicted impact: Low
Chinese approval for affiliate's botulinum toxin; small relative to parent company's size.
Also known as: GC WellBeing / 녹십자웰빙 / 234690 / KRX:234690
Source: KRX statistical information